Haemonetics CorporationHAENYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank87
3Y CAGR+1.5%
5Y CAGR+8.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+1.5%/yr
vs +13.2%/yr prior
5Y CAGR
+8.5%/yr
Recent deceleration
Acceleration
-11.7pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $61.23M | -11.8% |
| 2025 | $69.42M | +10.1% |
| 2024 | $63.03M | +7.5% |
| 2023 | $58.63M | +6.2% |
| 2022 | $55.20M | +35.8% |
| 2021 | $40.66M | +4.0% |
| 2020 | $39.08M | +9.4% |
| 2019 | $35.71M | -9.0% |
| 2018 | $39.23M | -17.0% |
| 2017 | $47.26M | - |